Genetically altered mice deficient in functional caspase-9
US7323616B2 · kind B2 · utility
0Cited by
5References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 1, 2000 |
| Grant date | Jan 29, 2008 |
| Priority date | — |
| Expiry date | Dec 1, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to genetically manipulated animals that are deficient in the expression of Caspase-9, a protein involved in programmed cell death. The invention further relates to methods for preventing specific types of cell death associated with Caspase-9 activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.